Skip to content

Braveheart Bio, Inc.

BRVE· NasdaqCore metricsCIK 2131524

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.61%
Market cap
$1.84B
89.87M shares
Filings
53
—
—
—
-$26.50M
Q3 2026
—
-$30.15M
Q3 2026
—
-$46.54M
Q3 2026derived
—
-$0.51
Q3 2026
—
$121.29M
Q3 2026
$1.84B
—
—
3.7×
—
—

FY2026 figures · derived

Price

$20.4831.29%$9.33since Aug 6, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$17.54MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Braveheart Bio, Inc. is the 101st largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Braveheart Bio, Inc. · CIK 2131524 · Engraved from SEC EDGAR